NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE227699 Query DataSets for GSE227699
Status Public on Oct 06, 2023
Title The Transcription Factor IRF4 Determines the Anti-Tumor Immunity of CD8+ T cells
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Four TIL populations from B16-F10 melanoma were analyzed by scRNA-seq, including adoptively transterred anti-tumor CD8+ Pmel-1 T cells that were transduced with IRF4 (sample 1, IRF4_Pmel) or GFP control (Sample 3, Ctrl_Pmel), and CD45+ endogenous TILs from either the IRF4 group (Sample 2, IRF4_TILs) or Ctrl group (Sample 4, Ctrl_TILS).
 
Overall design scRNAseq analysis of TILs from B16-F10 melanoma was performed.
 
Contributor(s) Hui Y, Zou D, Chen W, Dai Y
Citation(s) 37860697
Submission date Mar 20, 2023
Last update date Oct 31, 2023
Contact name Yulin Dai
E-mail(s) Yulin.Dai@uth.tmc.edu
Organization name University of Texas health science center at Houston
Department School of Biomedical Informatics
Street address 7000 fannin, suite 600
City Houston
State/province TX
ZIP/Postal code 77030
Country USA
 
Platforms (1)
GPL9185 Illumina Genome Analyzer (Mus musculus)
Samples (4)
GSM7105809 IRF4_Pmel
GSM7105810 IRF4_TILs
GSM7105811 Ctrl_Pmel
Relations
BioProject PRJNA946670

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE227699_RAW.tar 181.0 Mb (http)(custom) TAR (of MTX, TSV)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap